Electronic Cigarettes in Daily Dependent Smokers

Center for Addiction and Mental Health (CAMH)

Status and phase: Completed; Phase 4

Conditions: Nicotine Dependence; Substance Withdrawal Syndrome

Treatments: Drug: Placebo; Drug: Nicotine

Study type: Interventional

Funder types: Other

Identifiers

NCT02108626

001/2014

Details and patient eligibility

About

The aim of this study is to measure nicotine cue- and withdrawal-induced craving in current smokers under four distinct conditions: after smoking a conventional cigarette, an electronic cigarette (e-Cigarette) containing nicotine, an e-Cigarette without nicotine, and after taking a nicotine lozenge. Participants will be asked to attend four morning study visits after overnight smoking abstinence. Standardized questionnaires will be used to assess changes under each condition, allowing for the investigation of the efficacy of e-Cigarettes in reducing craving by replacing the behavioral component of smoking with minimal risk of adverse effects.

Full description

Many addiction models postulate stimuli to be linked with nicotine intake and reward after prolonged use. As such, smoking becomes more heavily based in habit, initiated by cues. Craving has been found to be a crucial component of continued smoking and relapse in response to various environmental and behavioral cues. Electronic Cigarettes (e-Cigarettes) are new smoking products emerging in consumer markets that often mimic conventional tobacco cigarettes. E-Cigarettes commonly include a cartridge, a heating element, a puff sensor, and a battery. When a user draws on the device, the heating element is activated and the cartridge fluid is vaporized. Users then inhale the aerosol containing droplets of the vaporized fluid. This study will empirically assess the efficacy of e-Cigarettes in alleviating craving by replacing the behavioral component of smoking. Using standardized questionnaires, intra-subject changes in cue- and withdrawal-induced craving after smoking an e-Cigarette without nicotine will be compared with that after either smoking a conventional cigarette, an e-Cigarette with nicotine, or taking a 4mg lozenge.

Enrollment: 43 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Current daily smoker
• Smoke minimum of 10 cigarettes per day
• Fagerstrom Test of Nicotine Dependence Score equal or greater than 3
• Never used an e-Cigarette prior to the study
• No intention to quit smoking within the next 3 months
• Able to provide written informed consent
• Able and willing to attend scheduled appointments

Exclusion criteria

• Any serious medical or unstable psychiatric problems requiring treatment
• Pregnancy or lactation

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

43 participants in 2 patient groups, including a placebo group

E-Cigarette with nicotine

Active Comparator group

Description:

Electronic cigarette with cartridge fluid containing nicotine

Treatment:

Drug: Nicotine

E-Cigarette without nicotine

Placebo Comparator group

Description:

Electronic cigarette with cartridge fluid containing no nicotine (placebo)

Treatment:

Drug: Placebo